Abstract
Patients with heart failure (HF) may develop a range of bradyarrhythmias including sinus node dysfunction, various degrees of atrioventricular block, and ventricular conduction delay. Device implantation has been recommended in these patients, but the specific etiology should be sought as it may influence the choice of the type of device required (pacemaker vs. implantable cardiac defibrillator). Also, pacing mode must be carefully set in patients with heart failure (HF) and left ventricular systolic dysfunction.
In this chapter, we summarize the knowledge required for a tailored approach to bradyarrhythmias in patients with heart failure.
The original version of this chapter has been revised. An erratum to this chapter can be found at https://doi.org/10.1007/5584_2018_198
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adan V, Crown LA (2003) Diagnosis and treatment of sick sinus syndrome. Am Fam Physician 67:1725–1732
Algalarrondo V, Dinanian S, Juin C et al (2012) Prophylactic pacemaker implantation in familial amyloid polyneuropathy. Heart Rhythm 9:1069–1075
Auricchio A, Salo RW (1997) Acute hemodynamic improvement by pacing in patients with severe congestive heart failure. Pacing Clin Electrophysiol 20:313–319
Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237
Barold SS, Hayes DL (2001) Second-degree atrioventricular block: a reappraisal. Mayo Clin Proc 76:44–57
Barra SN, Providência R, Paiva L et al (2012) A review on the advanced atrioventricular block in young or middle-aged adults. Pacing Clin Electrophysiol 35:1395–1405
Batra AS, Epstein D, Silka MJ (2003) The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol 24:495–497
Bayés de Luna A (2011) Passive arrhythmias, 1st edn. Wiley-Blackwell, Oxford
Bharati S, Goldschlager N, Kusumoto F et al (2012) Sinus node dysfunction. In: Camm AJ, Saksena S (eds) Electrophysiological disorders of the heart, 2nd edn. Elsevier Churchill-Livingstone, Philadelphia, pp 207–226
Bindoff L (2003) Mitochondria and the heart. Eur Heart J 24:221–224
Birnie DH, Sauer WH, Bogun F et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1305–1323
Brignole M (2002) Sick sinus syndrome. Clin Geriatr Med 18:211–227
Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15:1070–1118
Cattin ME, Muchir A, Bonne G (2013) ‘State-of-the-heart’ of cardiac laminopathies. Curr Opin Cardiol 28:297–304
Choudhury M, Boyett MR, Morris GM (2015) Biology of the sinus node and its disease. Arrhythm Electrophysiol Rev 4:28–34
Cleland JG, Swedberg K, Cohen-Solal A et al (2000) The Euro Heart Failure Survey of the EUROHEART survey program. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for the Health Economics University of York. Eur J Heart Fail 2:123–132
Dobrzynski H, Boyett MR, Anderson RH (2007) New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation 115:1921–1932
Dresing TJ, Natale A (2001) Congestive heart failure treatment: the pacing approach. Heart Fail Rev 6:15–25
Falk RH (2005) Diagnosis and management of the cardiac amyloidoses. Circulation 112:2047–2060
Finsterer J, Stöllberger C, Keller H (2012) Arrhythmia-related work up in hereditary myopathies. J Electrocardiol 45:376–384
Finsterer J, Stöllberger C, Maeztu C (2016) Sudden cardiac death in neuromuscular disorders. Int J Cardiol 203:508–515
García Ropero Á, Aceña Navarro Á, Farré Muncharaz J (2015) Cardiac amyloidosis and pacemakers: could devices delay diagnosis? Rev Esp Cardiol 68:253–259
Garman SC, Garboczi DN (2004) The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol 337:319–335
Groh WJ (2012) Arrhythmias in the muscular dystrophies. Heart Rhythm 9:1890–1895
Haines DE, Beheiry S, Akar JG et al (2014) Heart Rythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety. Heart Rhythm 11:19–23
Hamzeh N, Steckman DA, Sauer WH, Judson MA (2015) Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol 12:278–288
Hermans MC, Pinto YM, Merkies IS et al (2010) Hereditary muscular dystrophies and the heart. Neuromuscul Disord 20:479–492
Josephson ME (2008) Sinus node function. In: Clinical cardiac electrophysiology: techniques and interpretations, 4th edn. Lippincott, Williams, & Wilkins, Philadelphia, pp 69–92
Kandolin R, Lehtonen J, Kupari M (2011) Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 4:303–309
Kim JS, Judson MA, Donnino R (2009) Cardiac sarcoidosis. Am Heart J 157:9–21
Kim JH, Lee BH, Hyang Cho J et al (2016) Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes. J Hum Genet 61:923–929
Køber L, Thune JJ, Nielsen JC et al (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375:1221–1230
Kumar S, Barbhaiya C, Nagashima K et al (2015) Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol 8:87–93
Limongelli G, Masarone D, D’Alessandro R, Elliott PM (2012) Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. Futur Cardiol 8:71–88
Limongelli G, D’Alessandro R, Maddaloni V et al (2013) Skeletal muscle involvement in cardiomyopathies. J Cardiovasc Med 14:837–861
Limongelli G, Masarone D, Pacileo G (2016) Mitochondrial disease and the heart. Heart 1:12–25
Linhart A, Kampmann C, Zamorano JL et al (2007) Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J 28:1228–1235
Link MS, Berkow LC, Kudenchuk PJ et al (2015) Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 132:444–464
Lo R, Menzies DJ, Archer H, Cohen TJ (2003) Complete heart block due to Lyme carditis. J Invasive Cardiol 15:367–369
Lucon A, Palud L, Pavin D et al (2013) Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy. Arch Cardiovasc Dis 106:373–381
Luu M, Stevenson LW, Brunken RC et al (1989) Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 80:1675–1680
Mangrum JM, DiMarco JP (2000) The evaluation and management of bradycardia. N Engl J Med 342:703–709
Manios EG, Kanoupakis EM, Mavrakis HE et al (2001) Sinus pacemaker function after cardioversion of chronic atrial fibrillation: is sinus node remodeling related with recurrence? J Cardiovasc Electrophysiol 12:800–806
Masarone D, Limongelli G, Rubino M et al (2017) Management of arrhythmias in heart failure. J Cardiovasc Dev Dis 4:1–20
Mathew V, Olson LJ, Gertz MA et al (1997) Symptomatic conduction system disease in cardiac amyloidosis. Am J Cardiol 80:1491–1492
McVay MR (1984) Atrioventricular block a review. S D J Med 37:21–26
Montaigne D, Pentiah AD (2015) Mitochondrial cardiomyopathy and related arrhythmias. Card Electrophysiol Clin 7:293–301
Morris GM, Kalman JM (2014) Fibrosis, electrics and genetics. Perspectives in sinoatrial node disease. Circ J 78:1272–1282
Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883
Mullins CB, Atkins JM (1976) Prognoses and management of ventricular conduction blocks in acute myocardial infarction. Mod Concepts Cardiovasc Dis 45:129–131
Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224–1234
Nicod P, Gilpin E, Dittrich H et al (1988) Long-term outcome in patients with inferior myocardial infarction and complete atrioventricular block. J Am Coll Cardiol 12:589–594
O’Mahony C, Elliott P (2010) Anderson-Fabry disease and the heart. Prog Cardiovasc Dis 52:326–335
O’Mahony C, Coats C, Cardona M et al (2011) Incidence and predictors of anti-bradycardia pacing in patients with the Anderson-Fabry disease. Europace 13:1781–1788
O’Rourke RA (1972) Clinical cardiology: the stokes-Adams syndrome—definition and etiology; mechanisms and treatment. Calif Med 117:96–99
Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975
Priori SG, Blomström-Lundqvist C, Mazzanti A et al (2015) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36:2793–2867
Rankin J, Ellard S (2006) The laminopathies: a clinical review. Clin Genet 70:261–274
Rapezzi C, Quarta CC, Riva L et al (2010) Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol 7:398–408
Rapezzi C, Arbustini E, Caforio AL et al (2013) Diagnostic workup in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:1448–1458
Rubart M, Zipes DP (2014) Arrhythmias, sudden death, and syncope. In: Libby P, Bonow RO, Mann DL, Zipes D (eds) Braunwald’s heart disease, 10th edn. Saunders Elsevier, Philadelphia, pp 909–921
Schwartzmann D (2014) Atrioventricular block and atrioventricular dissociation. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology: from cell to bedside, 6th edn. Saunders, Philadelphia, pp 485–499
Sinagra G, Anzini M, Pereira NL et al (2016) Myocarditis in clinical practice. Mayo Clin Proc 91:1256–1266
Sneddon JF, Camm AJ (1992) Sinus node disease. Current concepts in diagnosis and therapy. Drugs 44:728–737
Solbiati M, Costantino G, Casazza G et al (2016) Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. Cochrane Database Syst Rev 4
Stevenson WG, Ellison KE, Sweeney MO et al (2002) Management of arrhythmias in heart failure. Cardiol Rev 10:8–14
Sweeney MO, Prinzen FW (2006) A new paradigm for physiologic ventricular pacing. J Am Coll Cardiol 47:282–290
Sweeney MO, Hellkamp AS, Ellenbogen KA et al (2003) Mode Selection Trial Investigators. The adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2938
Sylvius N, Tesson F (2006) Lamin A/C and cardiac diseases. Curr Opin Cardiol 21:159–165
Tans C, Lie KI, Durrer D (1980) Clinical setting and prognostic significance of high degree atrioventricular block in acute inferior myocardial infarction: a study of 144 patients. Am Heart J 99:4–8
Tellez JO, Mczewski M, Yanni J et al (2011) Ageing-dependent remodeling of ion channel and Ca2+ clock genes underlying sino-atrial node pacemaking. Exp Physiol 96:1163–1178
Tracy CM, Epstein AE, Darbar D et al (2012) 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 12:1784–1800
Van Rijsingen IA, Arbustini E, Elliott PM et al (2012) Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 59:493–500
Vogler J, Breithardt G, Eckardt L (2012) Bradyarrhythmias and conduction blocks. Rev Esp Cardiol 65:656–667
Waller BF, Gering LE, Branyas NA et al (1993) Anatomy, histology, and pathology of the cardiac conduction system – Part III. Clin Cardiol 16:436–442
Weatherall DJ, Ledingham JGG, Warrell DA (2010) Amyloidosis. In: Warrell DA, Cox TM, Firth JD (eds) Oxford textbook of medicine, 5th edn. University Press, Oxford, pp 1512–1524
Wilkoff BL, Cook JR, Epstein AE et al (2002) Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288:3115–3122
Wung SF (2016) Bradyarrhythmias: clinical presentation, diagnosis, and management. Crit Care Nurs Clin North Am 28:297–308
Yilmaz A, Secthem U (2012) Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy. Heart 98:420–428
Zoob M, Smith KS (1963) The etiology of complete heart-block. Br Med J 2:1149–1153
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Masarone, D. et al. (2017). Management of Bradyarrhythmias in Heart Failure: A Tailored Approach. In: Islam, M. (eds) Heart Failure: From Research to Clinical Practice. Advances in Experimental Medicine and Biology(), vol 1067. Springer, Cham. https://doi.org/10.1007/5584_2017_136
Download citation
DOI: https://doi.org/10.1007/5584_2017_136
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78279-9
Online ISBN: 978-3-319-78280-5
eBook Packages: MedicineMedicine (R0)